£1 Billion Boost for UK Life Sciences
New funding is available for the UK’s most promising life sciences companies, with the potential to crowd in further funding from other investors…
Tag Archive for: Healthcare
LSX Nordic Congress 6-17 September 2021
Optimum is proud to partner with The LSX Nordic Congress, one of the leading strategy, investment and partnering conference for the Nordic life science and healthcare industry. Register now…
International Women’s Day 2021
To celebrate, we asked the brilliant women in our sector their one main positive to come from the pandemic.
Doing the Right Right Thing, and Doing it Better: A Life Sciences Primer on ESG
To be credible and investible, ESG is becoming critical to the fund manager’s perspective, as investors shift further to sustainable investment.
BioWorld Article by Mike Ward on Medicxi’s launch of Centessa Pharmaceuticals
Francesco de Rubertis, a co-founder of Medicixi Ventures, has unveiled the next generation of the venture-backed asset-centric biopharma model with the creation of Centessa Pharmaceuticals Ltd. The new company was created by acquiring, in all-share transactions, total control of 10 companies from the Medicxi portfolio. Read more at BioWorld.com
